BMPR2 and pulmonary arterial hypertension: Recent European guidelines for the management of PAH recommend offering genetic counselling and screening for BMPR2 mutations to patients diagnosed with idiopathic, heritable, and anorexigen-associated PAH, mainly to enable predictive genetic testing of relatives.12